BlogZone Get the app

Business

The Potential Havoc Of Generic Drug Tariffs

Forbes Business 22 Jul 2026 1 views

In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.

BlogZone shows headlines and summaries from public news feeds. The full story is published by Forbes Business.

Read the full story at Forbes Business →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Business

The United States Navy Is Scuttling The Long-Worn Peacoat Next Year

The iconic peacoat is among several items being retired as part of the ongoing “seabag reduction” effort that will also phase out the acrylic V-neck sweater.

Forbes Business · 2 hours ago

Why A Petition To Cancel ‘The Body’ Just Hit 90,000 Signatures

A group wanted Netflix to cancel 'The Body' before it even aired, and a petition to do so is still racking up signatures. Why?

Forbes Business · 3 hours ago

Emiliano Vargas Says He Signed An Undisputed Deal And Was Scanned. So Why Isn’t He In The Game?

Unbeaten boxer Emiliano Vargas says he signed a deal and was scanned for Undisputed but isn’t in the game. Here’s what he said, and what it means for Undisputed 2.

Forbes Business · 3 hours ago